Verrica Pharmaceuticals Inc (VRCA)
0.9945
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 16:00
1.00
+0.01
(+0.55%)
After-Hours: 20:00
Verrica Pharmaceuticals Cash from Operations (Quarterly): -8.558M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -8.558M |
| June 30, 2024 | -16.36M |
| March 31, 2024 | -19.95M |
| December 31, 2023 | -14.51M |
| September 30, 2023 | -14.81M |
| June 30, 2023 | -4.669M |
| March 31, 2023 | -4.59M |
| December 31, 2022 | -4.954M |
| September 30, 2022 | 1.825M |
| June 30, 2022 | -7.181M |
| March 31, 2022 | -8.34M |
| December 31, 2021 | -8.698M |
| September 30, 2021 | -10.60M |
| June 30, 2021 | 2.499M |
| March 31, 2021 | -10.78M |
| December 31, 2020 | -6.099M |
| Date | Value |
|---|---|
| September 30, 2020 | -7.608M |
| June 30, 2020 | -8.594M |
| March 31, 2020 | -7.906M |
| December 31, 2019 | -8.213M |
| September 30, 2019 | -7.228M |
| June 30, 2019 | -5.05M |
| March 31, 2019 | -6.917M |
| December 31, 2018 | -6.903M |
| September 30, 2018 | -5.137M |
| June 30, 2018 | -3.68M |
| March 31, 2018 | -2.154M |
| December 31, 2017 | -1.847M |
| September 30, 2017 | -1.075M |
| June 30, 2017 | -1.152M |
| March 31, 2017 | -0.509M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-19.95M
Minimum
Mar 2024
2.499M
Maximum
Jun 2021
-8.405M
Average
-8.276M
Median
Cash from Operations (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 221.48M |
| Elite Pharmaceuticals Inc | 1.457M |
| Eagle Pharmaceuticals Inc | -0.126M |
| TELA Bio Inc | -8.983M |
| Terns Pharmaceuticals Inc | -16.46M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.016M |
| Cash from Financing (Quarterly) | -0.397M |
| Free Cash Flow | -59.62M |
| Free Cash Flow Per Share (Quarterly) | -0.1832 |
| Free Cash Flow to Equity (Quarterly) | -9.128M |
| Free Cash Flow Yield | -128.9% |